India's Metropolis Healthcare down after Q2 profit fall
** Shares of Metropolis Healthcare METP.NS down 2.4% at
1,535.25 rupees
** Diagnostics firm reported a 12.1% fall in Q2 net profit;
total expenses rose nearly 5%, dragged by a jump in employee
costs
** Of the 13 analysts tracking METP, five have "buy" or
"strong buy" rating, one "hold," seven "sell" or "strong sell;"
median TP is 1,462.50 rupees - LSEG data
** Stock up about 16% YTD
(Reporting by Navamya Ganesh Acharya in Bengaluru)
((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))
Recent news on Metropolis Healthcare
See all newsBrief: Metropolis Healthcare Q2fy27 Revenue Grew About 15% Year-On-Year
Brief: Metropolis Health Says Unit Metropolis Quality Solutions Enters Share Subscription And Shareholder's Agreements
Brief: Metropolis Health June-Quarter Consol Net Profit 566.7 Million Rupees
Brief: Metropolis Health Declares 2Nd Interim Dividend Of 1 Rupee Per Share
Brief: Metropolis Health March-Quarter Consol Net Profit 509 Million Rupees